Stopping, starting, and sustaining HIV antiretroviral therapy: a mixed-methods exploration among African American/Black and Latino long-term survivors of HIV in an urban context.

Journal: BMC public health

Volume: 21

Issue: 1

Year of Publication: 2021

Affiliated Institutions:  Center for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA. marya.gwadz@nyu.edu. Center for Drug Use and HIV/HCV Research (CDUHR), New York University School of Global Public Health, New York, NY, USA. Independent Consultant, Brooklyn, NY, USA. Department of Human Development, State University of New York at Binghamton, Binghamton, NY, USA. Methodology Center and Department of Human Development and Family Studies, Pennsylvania State University, State College, PA, USA. New York University Silver School of Social Work, New York, NY, USA. New York University School of Medicine, New York, NY, USA.

Abstract summary 

Although periods of HIV antiretroviral therapy (ART) discontinuation have deleterious health effects, ART is not always sustained. Yet, little is known about factors that contribute to such ART non-persistence among long-term HIV survivors. The present study applied a convergent parallel mixed-methods design to explore the phenomena of stopping/starting and sustaining ART, focusing on low-socioeconomic status African American or Black and Latino persons living with HIV (PLWH) who face the greatest challenges.Participants (N = 512) had poor engagement in HIV care and detectable HIV viral load. All received structured assessments and N = 48 were randomly selected for in-depth interviews. Quantitative analysis using negative binomial regression uncovered associations among multi-level factors and the number of times ART was stopped/started and the longest duration of sustained ART. Qualitative data were analyzed using a directed content analysis approach and results were integrated.Participants were diagnosed 18.2 years ago on average (SD = 8.6), started ART a median five times (Q1 = 3, Q3 = 10), and the median longest duration of sustained ART was 18 months (Q1 = 6, Q3 = 36). Factors associated with higher rates of stops/starts were male sex, transgender identity, cannabis use at moderate-to-high-risk levels, and ART- and care-related stigma. Factors associated with lower rates of stops/starts were older age, more years since diagnosis, motivation for care, and lifetime injection drug use (IDU). Factors associated with longer durations of sustained ART were Latino/Hispanic ethnicity, motivation for ART and care, and recent IDU. Factors associated with a shorter duration were African American/Black race, alcohol use at moderate-to-high-risk levels, and social support. Qualitative results uncovered a convergence of intersecting risk factors for stopping/starting ART and challenges inherent in managing HIV over decades in the context of poverty. These included unstable housing, which contributed to social isolation, mental health distress, and substance use concerns, the latter prompting selling ("diverting") ART. Primarily complementary quantitative and qualitative findings described mechanisms by which risk/protective factors operated and ways PLWH successfully restart and/or sustain ART.The field focuses substantially on ART adherence, but greater attention to reducing the frequency of ART non-persistence is needed, along with creating social/structural conditions favorable for sustained ART.

Authors & Co-authors:  Gwadz Marya M Cleland Charles M CM Freeman Robert R Wilton Leo L Collins Linda M LM L Hawkins Robert R Ritchie Amanda S AS Leonard Noelle R NR Jonas Danielle F DF Korman Alexis A Cluesman Sabrina S He Ning N Sherpa Dawa D

Study Outcome 

Source Link: Visit source

Statistics
Citations :  UNAIDS . 90–90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2014.
Authors :  13
Identifiers
Doi : 419
SSN : 1471-2458
Study Population
Male
Mesh Terms
Black or African American
Other Terms
Disparities;HIV antiretroviral therapy;HIV survivorship;Initiation;Mixed methods;Non-persistence;Poverty;Race/ethnicity;Resilience;Substance use
Study Design
Cross Sectional Study
Study Approach
Quantitative,Qualitative
Country of Study
Publication Country
England